摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

对苯二甲酸二叔丁酯 | 28313-42-0

中文名称
对苯二甲酸二叔丁酯
中文别名
——
英文名称
di-tert-butyl terephthalate
英文别名
Terephthalsaeure-di-tert-butylester;terephthalic acid-di-tert-butyl ester;ditert-butyl benzene-1,4-dicarboxylate
对苯二甲酸二叔丁酯化学式
CAS
28313-42-0
化学式
C16H22O4
mdl
——
分子量
278.348
InChiKey
JAIQCFIFVNAAAY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    119.5-120 °C
  • 沸点:
    175 °C(Press: 0.5 Torr)
  • 密度:
    1.052±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 危险性防范说明:
    P261,P280,P305+P351+P338,P304+P340
  • 危险性描述:
    H302

SDS

SDS:ff1cacdba74c3c48e96fc5886c180d9b
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones
    摘要:
    A series of tripeptides possessing trifluoromethyl or aryl ketone residues at P1 were prepared and evaluated both in vitro and in vivo as potential inhibitors of human leukocyte elastase (HLE). Tripeptides containing non naturally occurring N-substituted glycine residues at the P2-position have been demonstrated to be potent in vitro inhibitors of HLE, with IC50 values in the submicromolar range. Sterically demanding substituents on the P2-nitrogen have no detrimental effect on in vitro potency. The inhibition process presumably acts via hemiketal formation with the active site Ser195 of HLE, and is facilitated by the strongly electron withdrawing trifluoromethyl functionality. Deletion of the amino acid at the P3-subsite region affords inactive compounds. Valine is the preferred residue at the P1-position, whereas the corresponding glycine, alanine, alpha,alpha-dimethylglycine, or phenylalanine analogues are all inactive. The compounds described herein all confer a high degree of in vitro specificity when tested against representative cysteine, aspartyl, metallo, and other serine proteases. One of the most potent in vitro inhibitors is (3RS)-N-[4-[[[(4-chlorophenyl)sulfonyl]amino]carbonyl]phenyl]oxomethyl]-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycine N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]amide (20i; BI-RA-260) (IC50 = 0.084-mu-M). Compound 20i was also tested in hamsters in an elastase-induced pulmonary hemorrhage (EPH) model. In this model, intratracheal (it.) administration of 20i, 5 min prior to HLE challenge, effectively inhibited hemorrhage in a dose-dependent manner with an ED50 of 4.8-mu-g. The inhibitor 20i, 20-mu-g administered it. 24, 48, and 72 h prior to HLE challenge, exhibits significant inhibition against hemorrhage at all time points (97%, 64% and 49%, respectively). In a 21-day chronic model of emphysema in hamsters, 200-mu-g of HLE administered it. caused an elastase-induced emphysema in the lungs which can be quantitated histologically utilizing image analysis. In this assay, 20i significantly inhibited pulmonary lesions associated with septal destruction and increased alveolar spaces, when dosed at 20-mu-g it. 5 min prior to challenge with HLE.
    DOI:
    10.1021/jm00082a005
  • 作为产物:
    描述:
    对苯二甲酰氯吡啶 作用下, 以 叔丁醇 为溶剂, 生成 对苯二甲酸二叔丁酯
    参考文献:
    名称:
    Selected difluoro derivatives
    摘要:
    该发明披露了一系列二氟酮、单肽、二肽和三肽衍生物的化学式Ia、Ib和Ic:______________________________________(见示例后的页面上的化学式)Ia(见示例后的页面上的化学式)Ib(见示例后的页面上的化学式)Ic______________________________________PAL及其适当的盐,其中这些基团在规范中有定义。这些衍生物在抑制人白细胞弹性蛋白酶的作用方面是有用的。还公开了制造这些衍生物的方法和中间体,以及包括这些衍生物的药物组合物。
    公开号:
    US04880780A1
点击查看最新优质反应信息

文献信息

  • Retinoid-like compounds
    申请人:Bristol-Myers Squibb Company
    公开号:US05618839A1
    公开(公告)日:1997-04-08
    The present invention relates to a compound of formula I ##STR1## or a nontoxic pharmaceutically acceptable salt, physiologically hydrolyzable ester or solvate thereof, in which X is --O--CO--, --NH--CO--, --CS--NH--, --CO--O--, --CO--NH--, --COS--, --SCO--, --SCH.sub.2 --, --CH.sub.2 --CH.sub.2 --, --C.tbd.C--, --CH.sub.2 --NH--, --COCH.sub.2 --, --NHCS--, --CH.sub.2 S--, --CH.sub.2 O--, --OCH.sub.2 --, --NHCH.sub.2 -- or --CR.sup.5 .dbd.CR.sup.6 --; R.sup.m and R.sup.k are independently hydrogen, halogen, C.sub.1-6 alkyl, hydroxy, C.sub.1-6 alkyloxy or nitro; n is zero or one; R.sup.4 is --(CH.sub.2).sub.t --Y, C.sub.1-6 alkyl, or C.sub.3-6 cycloalkyl; R.sup.1 is --CO.sub.2 Z, C.sub.1-6 alkyl, CH.sub.2 OH, --CONHR.sup.y, or CHO; R.sup.2 and R.sup.3 are independently hydrogen or C.sub.1-6 alkyl; R.sup.a and R.sup.b are independently hydrogen or C.sub.1-6 alkyl; but when n is one, R.sup.a and R.sup.b together can form a radical of the formula ##STR2## Y is naphthyl or phenyl, both radicals can be optionally substituted with one to three same or different C.sub.1-6 alkyl or halogen; Z is hydrogen or C.sub.1-6 alkyl; R.sup.5, R.sup.6 and R.sup.y are independently hydrogen or C.sub.1-6 alkyl; and t is zero to six.
    该发明涉及式I的化合物##STR1##或其无毒的药学上可接受的盐、生理可水解的酯或溶剂化合物,其中X为--O--CO--、--NH--CO--、--CS--NH--、--CO--O--、--CO--NH--、--COS--、--SCO--、--SCH.sub.2--、--CH.sub.2--CH.sub.2--、--C.tbd.C--、--CH.sub.2--NH--、--COCH.sub.2--、--NHCS--、--CH.sub.2S--、--CH.sub.2O--、--OCH.sub.2--、--NHCH.sub.2--或--CR.sup.5.dbd.CR.sup.6--; R.sup.m和R.sup.k独立地为氢、卤素、C.sub.1-6烷基、羟基、C.sub.1-6烷氧基或硝基;n为零或一;R.sup.4为--(CH.sub.2).sub.t--Y、C.sub.1-6烷基或C.sub.3-6环烷基;R.sup.1为--CO.sub.2Z、C.sub.1-6烷基、CH.sub.2OH、--CONHR.sup.y或CHO;R.sup.2和R.sup.3独立地为氢或C.sub.1-6烷基;R.sup.a和R.sup.b独立地为氢或C.sub.1-6烷基;但当n为一时,R.sup.a和R.sup.b可以共同形成式的基团##STR2##Y为萘基或苯基,两个基团可以选择性地用一个到三个相同或不同的C.sub.1-6烷基或卤素取代;Z为氢或C.sub.1-6烷基;R.sup.5、R.sup.6和R.sup.y独立地为氢或C.sub.1-6烷基;t为零到六。
  • N-substituted amides
    申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
    公开号:US05221665A1
    公开(公告)日:1993-06-22
    N-substituted amides which inhibit hydrolysis of elastin, are described, which compounds are tri-and di- fluoromethyl ketone amide and non-naturally occurring n-substituted amino acids derivatives.
    描述了抑制弹性蛋白水解的N-取代酰胺,这些化合物是三氟甲基酮酰胺和二氟甲基酮酰胺以及非天然N-取代氨基酸衍生物。
  • An efficient method for the preparation of tert-butyl esters from benzyl cyanide and tert-butyl hydroperoxide under the metal free condition
    作者:Xiuling Chen、Yan Li、Minghu Wu、Haibing Guo、Longqiang Jiang、Jian Wang、Shaofa Sun
    DOI:10.1039/c6ra20966a
    日期:——
    A novel protocol to synthesize tert-butyl esters from benzyl cyanides and tert-butyl hydroperoxide has been successfully achieved. In the presence of tert-butyl hydroperoxide, Csp3–H bond oxidation, C–CN bond cleavage and C–O bond formation proceeded smoothly in one pot under the metal-free condition.
    从苄基氰化物和叔丁基氢过氧化物合成叔丁基酯的新方案已成功实现。在叔丁基过氧化氢的存在下,在无金属条件下,一锅中Csp 3 -H键的氧化,C-CN键的裂解和C-O键的形成顺利进行。
  • A simple, powerful, and efficient method for transesterification
    作者:Otto Meth-Cohn
    DOI:10.1039/c39860000695
    日期:——
    Aromatic and α,β-unsaturated methyl esters undergo efficient transesterification at ambient temperature or below with primary, secondary, or (particularly) tertiary alcohols in the presence of butyl-lithium in tetrahydrofuran solution.
    在丁基锂存在下于四氢呋喃溶液中,在环境温度以下,芳族和α,β-不饱和甲酯与伯,仲或(尤其是)叔醇进行有效的酯交换反应。
  • Zinc Promoted Mild and Efficient Method for the Esterification of Acid Chlorides with Alcohols
    作者:J.S. Yadav、Gondi SudershanReddy、Dale Srinivas、Konuru Himabindu
    DOI:10.1080/00397919808004286
    日期:1998.7
    The esterification of variety of acid chlorides with alcohols in the presence of zinc is described. The easy formation of t-butyl and pivaloyl esters are the additional importance of this procedure.
    描述了在锌存在下各种酰氯与醇的酯化反应。叔丁酯和新戊酸酯的容易形成是该程序的额外重要性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐